In fact, a new study shows, low-value care ... Nov. 4, 2024 — Remote medical interpreting (RMI) may be hindering healthcare communication rather than helping it, according to a new ...
AbbVie's IL-23 inhibitor Skyrizi trailed some of its rivals in its first indication psoriasis, but has leapfrogged into first place in Crohn's disease after getting approval for the new indication ...